L26/P-547 Recipient age and IVF outcomes: an analysis of 2594 donor oocyte recipient cycles
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.880 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von N. Sodani und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Study question Does recipient age influence live birth, clinical pregnancy, or miscarriage outcomes in IVF cycles using donor oocytes? Summary answer Recipient age was not associated with live birth, clinical pregnancy, or miscarriage rates in donor oocyte IVF cycles, supporting preserved uterine receptivity with advancing age. What is known already Female age is a major determinant of IVF success, largely driven by age-related oocyte aneuploidy. Donor oocyte cycles provide a unique model to isolate the contribution of uterine factors to reproductive outcomes. Although earlier studies suggest that implantation and pregnancy rates are preserved with increasing recipient age, concerns persist those age-related changes in endometrial receptivity, immune function, and vascularisation may adversely affect outcomes. Evidence remains conflicting, and large population-based analyses assessing the independent impact of recipient age on IVF outcomes using donor oocytes are limited. Study design, size, duration Anonymised data from the Human Fertilisation and Embryology Authority (HFEA) registry, the statutory national database capturing all assisted reproductive technology cycles performed in the UK, were analysed. Donor oocyte recipient IVF cycles undertaken between 2000 and 2018 were included and recipient age was defined as recipient age at embryo transfer. Data are prospectively collected and validated through routine regulatory oversight. Statistical analyses were performed using Stata IC version 19. Participants/materials, setting, methods To control for oocyte-related confounders, only cycles using donor oocytes from women aged ≤35 years were included. Recipients were categorised into four age groups: <35 years (reference group), 35–37 years, 37-39 years and ≥40 years. Associations between recipient age and live birth, clinical pregnancy, and miscarriage outcomes were assessed using multivariable logistic regression, adjusting for previous IVF cycles, previous live birth, IVF vs ICSI, treatment period, day of embryo transfer, and number of embryos transferred. Main results and the role of chance A total of 2,594 donor oocyte recipient IVF cycles were analysed. There was no significant difference in live birth rates across recipient age groups in donor oocyte recipient IVF cycles. Live birth rate occurred in 35.4% of cycles overall Using recipients aged <35 years as the reference group, live birth was similar among recipients aged 35–37 years (OR 1.31, 95% CI 0.74–2.31), 37-39 years (OR 0.9, 95% CI 0.50-1.63) and ≥40 years (OR 1.08, 95% CI 0.71–1.63). After adjustment for previous IVF cycles, previous live birth, fertilisation method (IVF vs ICSI), treatment period, day of embryo transfer, and number of embryos transferred, there remained no statistically significant association between recipient age and live birth outcome. Similarly, clinical pregnancy rates did not differ significantly across recipient age categories when compared with the <35-year reference group (35–39 years: OR 1.06, 95% CI 0.60–1.85; ≥40 years: OR 0.91, 95% CI 0.61–1.37), and these findings were unchanged after multivariable adjustment. Miscarriage risk was also comparable across recipient age groups (35–39 years: OR 0.87, 95% CI 0.33–2.30; ≥40 years: OR 0.96, 95% CI 0.47–1.96), with no significant differences observed after adjustment for potential confounders. Limitations, reasons for caution Registry data lacked information on donor characteristics, embryo quality, and endometrial preparation protocols. Residual confounding cannot be excluded despite multivariable adjustment. Wider implications of the findings These findings provide population-level reassurance that advancing recipient age does not adversely affect IVF outcomes when oocyte quality is controlled. This has important implications for patient counselling, equitable access to donor oocyte treatment, and informed decision-making for older women pursuing IVF. Trial registration number No
Zitieren
APA
Sodani, N., Chatzakis, C., Beebeejaun, Y., Sunkara, S., & Duffy, J. (2026). L26/P-547 Recipient age and IVF outcomes: an analysis of 2594 donor oocyte recipient cycles. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.880
Vancouver
Sodani N, Chatzakis C, Beebeejaun Y, Sunkara S, Duffy J. L26/P-547 Recipient age and IVF outcomes: an analysis of 2594 donor oocyte recipient cycles. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.880
BibTeX
@article{Sodani2026,
author = {Sodani, N. and Chatzakis, C. and Beebeejaun, Y. and Sunkara, S. and Duffy, J.},
title = {L26/P-547 Recipient age and IVF outcomes: an analysis of 2594 donor oocyte recipient cycles},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.880}
}
EUVIMED